BBS10
BBSome complex assembly protein BBS10
Also known as: BBS10_HUMAN, C12orf58, FLJ23560
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TAM1
- Gene
- BBS10
- Ensembl
- ENSG00000179941
- Chromosome
- 12
- Canonical length
- 723 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by progressive retinal degeneration, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene is likely not a ciliary protein but rather has distant sequence homology to type II chaperonins. As a molecular chaperone, this protein may affect the folding or stability of other ciliary or basal body proteins. Inhibition of this protein's expression impairs ciliogenesis in preadipocytes. Mutations in this gene cause Bardet-Biedl syndrome type 10. [provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
723 residues, UniProt reviewed canonical sequence.
>Q8TAM1|BBS10
1 MLSSMAAAGS VKAALQVAEV LEAIVSCCVG PEGRQVLCTK PTGEVLLSRN GGRLLEALHL
61 EHPIARMIVD CVSSHLKKTG DGAKTFIIFL CHLLRGLHAI TDREKDPLMC ENIQTHGRHW
121 KNCSRWKFIS QALLTFQTQI LDGIMDQYLS RHFLSIFSSA KERTLCRSSL ELLLEAYFCG
181 RVGRNNHKFI SQLMCDYFFK CMTCKSGIGV FELVDDHFVE LNVGVTGLPV SDSRIIAGLV
241 LQKDFSVYRP ADGDMRMVIV TETIQPLFST SGSEFILNSE AQFQTSQFWI MEKTKAIMKH
301 LHSQNVKLLI SSVKQPDLVS YYAGVNGISV VECLSSEEVS LIRRIIGLSP FVPPQAFSQC
361 EIPNTALVKF CKPLILRSKR YVHLGLISTC AFIPHSIVLC GPVHGLIEQH EDALHGALKM
421 LRQLFKDLDL NYMTQTNDQN GTSSLFIYKN SGESYQAPDP GNGSIQRPYQ DTVAENKDAL
481 EKTQTYLKVH SNLVIPDVEL ETYIPYSTPT LTPTDTFQTV ETLTCLSLER NRLTDYYEPL
541 LKNNSTAYST RGNRIEISYE NLQVTNITRK GSMLPVSCKL PNMGTSQSYL SSSMPAGCVL
601 PVGGNFEILL HYYLLNYAKK CHQSEETMVS MIIANALLGI PKVLYKSKTG KYSFPHTYIR
661 AVHALQTNQP LVSSQTGLES VMGKYQLLTS VLQCLTKILT IDMVITVKRH PQKVHNQDSE
721 DELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BBS10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 11 nTPM
- ovary: 11 nTPM
- breast: 11 nTPM
- adipose tissue: 11 nTPM
- retina: 11 nTPM
- heart muscle: 9.6 nTPM
Single-cell type
- thymic myoid cells: 26 nCPM
- alveolar cells type 1: 14 nCPM
- schwann cells: 12 nCPM
- mucous neck cells: 11 nCPM
- corticotrophs: 10 nCPM
- hepatocytes: 10 nCPM
Immune cell
- non-classical monocyte: 7.2 nTPM
- eosinophil: 5 nTPM
- intermediate monocyte: 4 nTPM
- basophil: 2.6 nTPM
- myeloid DC: 2.5 nTPM
- naive CD4 T-cell: 2.2 nTPM
Brain region
- white matter: 16 nTPM
- cerebellum: 13 nTPM
- spinal cord: 13 nTPM
- medulla oblongata: 12 nTPM
- pons: 12 nTPM
- basal ganglia: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BBS10.
Disease | AllUniProt
Conditions BBS10 is implicated in, by any mechanism.
- Bardet-Biedl syndrome 10 (BBS10) MIM:615987
Disease | GeneticClinVar
267 pathogenic / likely-pathogenic of 1,070 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bardet-Biedl syndrome 10
- Bardet-Biedl syndrome
- BBS10-related disorder
- Retinal dystrophy
- Bardet-Biedl syndrome 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chaperone-mediated protein complex assembly
- cone retinal bipolar cell differentiation
- intracellular protein localization
- negative regulation of neuron apoptotic process
- neuronal action potential
- non-motile cilium assembly
- photoreceptor cell maintenance
- regulation of protein-containing complex assembly
- response to endoplasmic reticulum stress
- response to light stimulus
- retinal cone cell differentiation
- retinal rod cell differentiation
- visual perception
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BBS10 as an antibody target. Whether an autoantibody or antibody against BBS10 could matter depends on whether native BBS10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BBS10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BBS10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...